Willibald Hochholzer
Overview
Explore the profile of Willibald Hochholzer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
111
Citations
2656
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ubben T, Tigges E, Kim W, Holzamer A, Breitenbach I, Sodian R, et al.
J Clin Med
. 2024 Jun;
13(11).
PMID: 38892875
The primary objective of this study was to evaluate the initial experience in Germany with the Meril Myval™ (MM) transcatheter heart valve (THV) system for the treatment of severe symptomatic...
2.
Aytekin A, Scalamogna M, Coughlan J, Lahu S, Ndrepepa G, Menichelli M, et al.
Clin Res Cardiol
. 2024 May;
113(7):1060-1069.
PMID: 38740722
Background: The ISAR-REACT 5 trial compared the efficacy and safety of ticagrelor and prasugrel in patients with ACS managed invasively. The present study sought to investigate the impact of ticagrelor...
3.
Giacoppo D, Alvarez-Covarrubias H, Koch T, Cassese S, Xhepa E, Kessler T, et al.
Eur Heart J
. 2023 Feb;
44(15):1343-1357.
PMID: 36807512
Aims: The best interventional strategy for the treatment of drug-eluting stent (DES) in-stent restenosis (ISR) is still unclear and no data from randomized trials beyond 3-year follow-up are available. We...
4.
Schlosser J, Herrmann L, Bohme T, Burgelin K, Loffelhardt N, Nuhrenberg T, et al.
Clin Res Cardiol
. 2022 Sep;
112(9):1175-1185.
PMID: 36074269
Objectives: This study investigated the contemporary incidence and predictors of radial artery occlusion as well as the effectiveness of antithrombotic treatment for radial artery occlusion following transradial coronary angiography. Background:...
5.
Corpataux N, Hochholzer W, Valina C, Ferenc M, Loffelhardt N, Westermann D, et al.
Curr Probl Cardiol
. 2022 Aug;
47(12):101362.
PMID: 36028053
We aimed at addressing the association between serum lipoprotein (a) levels and clinical outcomes of consecutive patients undergoing PCI. We used consecutive patients undergoing PCI at the Heart Center University...
6.
Kueri S, Berger T, Puiu P, Alhamami Y, Diab N, Czerny M, et al.
Thorac Cardiovasc Surg
. 2022 Aug;
71(7):542-549.
PMID: 35987191
Objectives: The Perceval valve was shown to facilitate minimal-invasive operations and shorten operative times. We aimed to compare the early results of the Perceval valve to those of well-established valves,...
7.
Behnes M, Lahu S, Ndrepepa G, Menichelli M, Mayer K, Wohrle J, et al.
Clin Res Cardiol
. 2022 Jul;
112(4):518-528.
PMID: 35789430
Objectives: To assess the efficacy and safety of ticagrelor versus prasugrel in patients with acute coronary syndrome (ACS) presenting during off- and on-hours. Background: The efficacy and safety of ticagrelor...
8.
Kille A, Franke K, Corpataux N, Hromek J, Valina C, Neumann F, et al.
J Clin Med
. 2022 May;
11(10).
PMID: 35628999
Dual anti-platelet therapy (DAPT) with clopidogrel and acetylsalicylic acid (ASA) has previously been recommended after transcatheter aortic valve implantation (TAVI) and is still the standard of care in patients who...
9.
Nuhrenberg T, Stockle J, Marini F, Zurek M, Gruning B, Benes V, et al.
PLoS One
. 2022 Jan;
17(1):e0260222.
PMID: 35085240
Background: Sepsis is associated with high platelet turnover and elevated levels of immature platelets. Changes in the platelet transcriptome and the specific impact of immature platelets on the platelet transcriptome...
10.
Lahu S, Behnes M, Ndrepepa G, Neumann F, Sibbing D, Bernlochner I, et al.
Rev Esp Cardiol (Engl Ed)
. 2021 Dec;
75(9):747-755.
PMID: 34961732
Introduction And Objectives: The efficacy and safety of ticagrelor vs prasugrel in patients with acute coronary syndromes (ACS) according to body mass index (BMI) remain unstudied. We assessed the efficacy...